These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31561219)

  • 1. Impact of facility type and volume in low-grade glioma outcomes.
    Zhu P; Du XL; Blanco AI; Ballester LY; Tandon N; Berger MS; Zhu JJ; Esquenazi Y
    J Neurosurg; 2020 Nov; 133(5):1313-1323. PubMed ID: 31561219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
    Zhu P; Du XL; Zhu JJ; Esquenazi Y
    J Neurosurg; 2020 Feb; 132(2):491-502. PubMed ID: 30771780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis.
    Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Culligan MJ; Friedberg JS; Simone CB
    Lung Cancer; 2018 Jun; 120():7-13. PubMed ID: 29748018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.
    Haque W; Verma V; Butler EB; Teh BS
    Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30052835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma.
    Torabi SJ; Benchetrit L; Kuo Yu P; Cheraghlou S; Savoca EL; Tate JP; Judson BL
    JAMA Otolaryngol Head Neck Surg; 2019 Aug; 145(8):708-715. PubMed ID: 31194229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer.
    Patel R; Patel AM; Revercomb L; Qie V; Tseng CC; Baredes S; Park RCW
    Laryngoscope; 2024 Jun; ():. PubMed ID: 38895869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
    Bollig CA; Zitsch RP
    Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers.
    David JM; Kim S; Placencio-Hickok VR; Torosian A; Hendifar A; Tuli R
    Adv Radiat Oncol; 2019; 4(2):302-313. PubMed ID: 31011675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of facility volume on giant pituitary adenoma neurosurgical outcomes.
    Chalif EJ; Couldwell WT; Aghi MK
    J Neurosurg; 2022 Sep; 137(3):658-667. PubMed ID: 35171824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary Thyroid Cancer.
    Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
    Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facility Volume and Survival in Nasopharyngeal Carcinoma.
    Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Lee NY; Ho AS; Zumsteg ZS
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):408-417. PubMed ID: 29100787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
    Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
    Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of facility type and volume on survival in patients with metastatic renal cell carcinoma.
    Dursun F; Elshabrawy A; Wang H; Oelsen J; Liss M; Kaushik D; Ramamurthy C; Rodriguez R; Mansour AM
    Can J Urol; 2021 Oct; 28(5):10806-10816. PubMed ID: 34657653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of facility type on intracranial meningioma treatment and outcomes: predicting overall survival using the National Cancer Database.
    Brown NJ; Gendreau J; Chakravarti S; Abraham BM; Mehkri Y; Kuo CC; Chowdhury N; Cohen-Gadol A
    J Neurosurg; 2024 Feb; 140(2):350-356. PubMed ID: 37877982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.
    D'Rummo KA; TenNapel MJ; Shen X
    Am J Clin Oncol; 2019 Sep; 42(9):705-710. PubMed ID: 31368905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case volume regionalization and volume-based outcome differences in cutaneous head and neck melanoma.
    Roman KM; Torabi SJ; Goshtasbi K; Kuan EC; Tjoa T; Haidar YM
    Head Neck; 2022 Nov; 44(11):2428-2436. PubMed ID: 35903986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States.
    Goyal A; Zreik J; Brown DA; Kerezoudis P; Habermann EB; Chaichana KL; Chen CC; Bydon M; Parney IF
    J Neurosurg; 2022 Jul; 137(1):32-41. PubMed ID: 34767534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.
    Wang EH; Rutter CE; Corso CD; Decker RH; Wilson LD; Kim AW; Yu JB; Park HS
    J Thorac Oncol; 2015 Jun; 10(6):937-43. PubMed ID: 25738221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.